Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Glavni autor: | Karim, Samia Binte |
---|---|
Daljnji autori: | Azam, Faruque |
Format: | Disertacija |
Jezik: | English |
Izdano: |
Brac University
2024
|
Teme: | |
Online pristup: | http://hdl.handle.net/10361/23944 |
Similar Items
-
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Izdano: (2024) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Izdano: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Izdano: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Izdano: (2024) -
Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
od: Hasan, Sakib
Izdano: (2024)